Search Results
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Valentina Cirello in
Google Scholar
PubMed
Search for other papers by Marina Lugaresi in
Google Scholar
PubMed
Search for other papers by Claudia Moneta in
Google Scholar
PubMed
Center for Interdisciplinary Research on Medicines (C.I.R.M.), University of Liege (ULiège), CHU (B35), Liege, Belgium
Search for other papers by Patrice Dufour in
Google Scholar
PubMed
Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Alessandro Manzo in
Google Scholar
PubMed
Search for other papers by Erika Carbone in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Center for Interdisciplinary Research on Medicines (C.I.R.M.), University of Liege (ULiège), CHU (B35), Liege, Belgium
Search for other papers by Corinne Charlier in
Google Scholar
PubMed
Center for Interdisciplinary Research on Medicines (C.I.R.M.), University of Liege (ULiège), CHU (B35), Liege, Belgium
Search for other papers by Catherine Pirard in
Google Scholar
PubMed
anaplastic TC (ATC)), while the remaining ten patients had a medullary thyroid cancer (MTC). The majority of cases had a T1 tumor without metastatic lymph nodes. About 57.3% of cases had a tumor size >10 mm, and about 66% had a BRAF V600E mutation. The